CBD Global Sciences EV / EBITDA
Was ist das EV / EBITDA von CBD Global Sciences?
EV / EBITDA von CBD Global Sciences Inc. ist N/A
Was ist die Definition von EV / EBITDA?
EV / EBITDA ist der Unternehmenswert geteilt durch das Einkommen vor Zinsen, Steuern, Abschreibungen und Amortisationen. Es ist ein Maß dafür, wie teuer eine Aktie ist und für Vergleiche zwischen Unternehmen häufiger gültig ist als das Preis-Gewinn-Verhältnis. Er misst den Preis (in Form des Unternehmenswerts), den ein Investor zu Gunsten des Cashflows des Unternehmens (in Form des EBITDA) bezahlt.
Price to earnings ratios are impacted by a company's choice of capital structure - companies which raise money via debt will have lower P/Es (and therefore look cheaper) than companies that raise an equivalent amount of money by issuing shares, even though the two companies might have equivalent enterprise values. A sample case is when a company with debt were to raise money by issuing shares of stock, and then used the money to pay off the debt, this company's P/E ratio would shoot up because of the increased number of shares - although nothing about the fundamental value of the business has changed. EV / EBITDA is unaffected by capital structure as enterprise value includes the value of debt, and EBITDA is available to all investors (debt and equity) as it excludes interest payments on that debt. It is ideal for analysts and potential investors looking to compare companies within the same industry.
EV / EBITDA von Unternehmen in Health Care Sektor auf OTC im Vergleich zu CBD Global Sciences
Was macht CBD Global Sciences?
CBD Global Sciences Inc. engages in cannabidiol (CBD) farming, processing, and product manufacturing business. It offers provides biomass, CBD oil, and CBD oil products under the Aethics, CannaOil, and Strasburg Pharms brand names. The company was incorporated in 2018 and is headquartered in Lakewood, Colorado.
Unternehmen mit ev / ebitda ähnlich CBD Global Sciences
- Atomo Diagnostics hat EV / EBITDA von N/A
- LXRandCo hat EV / EBITDA von N/A
- Exro Technologies Inc hat EV / EBITDA von N/A
- Pacific Imperial Mines hat EV / EBITDA von N/A
- Kalina Power hat EV / EBITDA von N/A
- TransAtlantic Petroleum Ltd hat EV / EBITDA von N/A
- CBD Global Sciences hat EV / EBITDA von N/A
- Paradigm Biopharmaceuticals hat EV / EBITDA von N/A
- Guided Therapeutics hat EV / EBITDA von N/A
- KRM22 Plc hat EV / EBITDA von N/A
- CMC Metals hat EV / EBITDA von N/A
- Lamaska Capital hat EV / EBITDA von N/A
- Riverside Resources hat EV / EBITDA von N/A